BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8417122)

  • 1. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC; Gewurz AT; Jiang H; Gewurz H
    J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
    J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
    Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
    Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
    Jiang H; Lint TF; Gewurz H
    Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
    Veerhuis R; Boshuizen RS; Morbin M; Mazzoleni G; Hoozemans JJ; Langedijk JP; Tagliavini F; Langeveld JP; Eikelenboom P
    Neurobiol Dis; 2005; 19(1-2):273-82. PubMed ID: 15837583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
    Sjöberg AP; Nyström S; Hammarström P; Blom AM
    Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional domains of the human C1q A-chain.
    Trinder PK; Maeurer MJ; Kaul M; Petry E; Loos M
    Behring Inst Mitt; 1993 Dec; (93):180-8. PubMed ID: 8172566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
    Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
    Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete cDNA sequence of SAP-like pentraxin from Limulus polyphemus: implications for pentraxin evolution.
    Tharia HA; Shrive AK; Mills JD; Arme C; Williams GT; Greenhough TJ
    J Mol Biol; 2002 Feb; 316(3):583-97. PubMed ID: 11866519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
    Jiang H; Robey FA; Gewurz H
    J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
    Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
    Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum amyloid P component binds to peripheral blood monocytes.
    Macdonald SL; Kilpatrick DC
    Scand J Immunol; 2006 Jul; 64(1):48-52. PubMed ID: 16784490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
    Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
    J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.